Related Experiment Video
Updated: Jun 28, 2026

Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
Draft genome sequence of a multidrug-resistant Streptococcus agalactiae sequence type 1665 strain isolated from
Saki Kanehira1, Yusuke Ota2, Kazunari Sonobe1
1Department of Clinical Laboratory, Institute of Science Tokyo Hospital, Tokyo, Japan.
Abstract:
Streptococcus agalactiae poses a threat due to increasing antimicrobial resistance and the potential for invasive disease. We isolated a sequence type 1665 strain nonsusceptible to β-lactams and resistant to macrolides, tetracyclines, and fluoroquinolones, harboring previously uncharacterized PBP2X variants, highlighting the need for genomic surveillance to guide treatment and infection control.
Insights
A drug-resistant Streptococcus agalactiae strain was identified, showing resistance to multiple antibiotics including beta-lactams. Genomic surveillance is crucial for managing invasive infections caused by such resistant bacteria.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Streptococcus agalactiae (Group B Streptococcus) is a significant pathogen.
- Increasing antimicrobial resistance in S. agalactiae complicates treatment and infection control.
- The potential for invasive disease necessitates ongoing surveillance.
Purpose of the Study:
- To characterize a novel strain of Streptococcus agalactiae with a concerning resistance profile.
- To identify genetic determinants contributing to antimicrobial resistance in this strain.
- To emphasize the importance of genomic surveillance for Streptococcus agalactiae.
Main Methods:
- Isolation and identification of Streptococcus agalactiae.
- Antimicrobial susceptibility testing (phenotypic characterization).
- Whole-genome sequencing to identify genetic mutations and resistance mechanisms, including analysis of PBP2X variants.
Main Results:
- A sequence type 1665 Streptococcus agalactiae strain was isolated.
- The strain exhibited nonsusceptibility to beta-lactams and resistance to macrolides, tetracyclines, and fluoroquinolones.
- Previously uncharacterized variants in the penicillin-binding protein 2X (PBP2X) were identified.
Conclusions:
- The emergence of multidrug-resistant Streptococcus agalactiae, including beta-lactam nonsusceptibility, poses a significant public health threat.
- Genomic surveillance is essential for early detection of resistant strains and informing clinical treatment strategies.
- Understanding resistance mechanisms, such as novel PBP2X variants, is critical for effective infection control and guiding antimicrobial therapy.
Related Concept Videos
Modern Molecular Taxonomy
Genomic DNA in Prokaryotes
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Evolution of Microbial Genome
